Atara Biotherapeutics, Inc.

BNP PARIBAS FINANCIAL MARKETS ATRA

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/1/2024

Shares

383,082

Value ($000)

266

Weight

0.0%

2019 Q4 - 2024 Q1 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/1/2024	266	0.0%	383,082	3/31/2024
2023 Q4	2/14/2024	152	0.0%	296,240	12/31/2023
2023 Q3	11/14/2023	29	0.0%	19,713	9/30/2023
2023 Q2	8/9/2023	122	0.0%	75,640	6/30/2023
2023 Q1	5/12/2023	748	0.0%	257,906	3/31/2023
2022 Q4	2/14/2023	351	0.0%	107,159	12/31/2022
2022 Q3	11/16/2022	749	0.0%	198,267	9/30/2022
2022 Q2	8/12/2022	209	0.0%	26,885	6/30/2022
2022 Q1	5/18/2022	124	0.0%	13,338	3/31/2022
2021 Q4	2/9/2022	775	0.0%	49,197	12/31/2021
2021 Q3	11/16/2021	521	0.0%	29,095	9/30/2021
2021 Q2	8/10/2021	329	0.0%	21,178	6/30/2021
2021 Q1	5/7/2021	518	0.0%	36,040	3/31/2021
2020 Q4	2/10/2021	2,086	0.0%	106,241	12/31/2020
2020 Q3	10/30/2020	222	0.0%	17,131	9/30/2020
2020 Q2	8/6/2020	115	0.0%	7,925	6/30/2020
2020 Q1	5/13/2020	234	0.0%	27,553	3/31/2020
2019 Q4	2/12/2020	105	0.0%	6,403	12/31/2019